As of 2024-12-14, the Intrinsic Value of ZIOPHARM Oncology Inc (ZIOP) is
-1.91 USD. This ZIOP valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.87 USD, the upside of ZIOPHARM Oncology Inc is
-320.34%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-1.91 USD
Intrinsic Value
ZIOP Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-1.91 - -1.91 |
-1.91 |
-320.34% |
| P/E |
(4.61) - (7.83) |
(7.43) |
-958.3% |
| DDM - Stable |
(9.90) - 85.71 |
37.91 |
4278.7% |
| DDM - Multi |
(9.19) - 60.95 |
(21.43) |
-2575.0% |
ZIOP Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
187.12 |
| Beta |
1.70 |
| Outstanding shares (mil) |
216.15 |
| Enterprise Value (mil) |
119.61 |
| Market risk premium |
4.24% |
| Cost of Equity |
5.25% |
| Cost of Debt |
5.00% |
| WACC |
4.45% |